- Trade war worries loom over Las Vegas tech show
- America mourns former president Jimmy Carter at state funeral
- Djokovic handed tough Australian Open draw, Sinner faces Jarry test
- Bok prop Nche wary of Dupont threat in Champions Cup
- Conceicao brings good vibes back to AC Milan after Super Cup triumph
- 'We have lost everything': Despair in the Los Angeles fires
- Australia frets over Meta halt to US fact-checking
- Japan startup hopeful ahead of second moon launch
- Ukraine allies to hold last defence meet before Trump takes office
- NBA-best Cavs win 11th in a row to end 15-game Thunder streak
- What you need to know about HMPV
- Venezuela braces for crunch anti-Maduro protests
- Bangladesh garment industry rebounds, but workers say little change
- Asian markets drop as trades fret over US inflation, rates outlook
- Mozambique opposition leader due home amid tension over disputed vote
- Doping and a match made in heaven: Australian Open storylines
- Australia recall McSweeney for Sri Lanka Tests, Connolly set for debut
- Myanmar military adopts anti-junta fighters' drone tactics
- Lebanon set to finally elect president after two-year vacancy
- New twist in US-Cuba trademark fight over Havana Club rum
- CES tech looks to help world's aging population
- Venezuela repression increases ahead of crunch anti-Maduro protests
- Rubber tappers forge sustainable future in Amazon
- 'No more fires,' demand fed-up Amazon residents
- Assault on Chad presidential complex leaves 19 dead
- Crowds throng as Jesus statue parades through Philippine capital
- Slot fumes after Spurs teenager Bergvall avoids red card to sink Liverpool
- Fighting at Chad presidency leaves 19 dead, several injured
- US astronauts upbeat seven months into eight-day mission
- Bergvall strikes as Spurs snatch League Cup semi-final lead over Liverpool
- Extreme weather, suburban sprawl fuel LA's wildfires
- Campaigners fear spike in hate speech as Meta lifts restrictions
- Yakuza leader pleads guilty in US court to conspiring to sell nuclear material
- Barcelona defeat Bilbao without Olmo to reach Spanish Super Cup final
- Displaced LA residents in shock at scale of fire destruction
- Gunfire erupts inside presidency in Chad capital
- Miami and Tampa to host outdoor NHL contests in 2026
- Popov claims first World Cup win in Madonna di Campiglio slalom
- Tottenham star Bentancur 'conscious' after head injury in Liverpool clash
- NHL Kings postpone game while NFL monitors LA area wildfires
- Barcelona defeat Athletic without Olmo to reach Spanish Super Cup final
- Bulgaria's Popov claims first World Cup win in Madonna di Campiglio slalom
- Niemann and Nicolai Hojgaard accept special Masters invitations
- Political chess or true beliefs? Zuckerberg's surprise Trump pivot
- Hosszu, swimming's 'Iron Lady', retires at 35
- US withholds $3.6 mln payment to WADA after no audit
- Venezuela opposition decry crackdown before Maduro swearing-in
- US Fed officials concerned over 'stalled' disinflation, tariffs: minutes
- Whole streets burn as fires rage around Los Angeles
- Celebrities flee Los Angeles fires as Hollywood events scrapped
Seven deaths in E.Guinea from Marburg virus, 20 others likely linked: WHO
Seven people have been killed in an outbreak of Marburg virus in Equatorial Guinea, with a further 20 deaths "probably" due to the hemorrhagic fever, the World Health Organization said Thursday.
The outbreak of the virus, which is almost as deadly as Ebola, has now spread beyond the province of Kie-Ntem, where it caused the first known deaths in January.
It has reached Bata, the economic capital of the small central African country, according to the government.
The spread of Marburg "is a critical signal to scale up response efforts to quickly stop the chain of transmission and avert a potential large-scale outbreak and loss of life," said Dr Matshidiso Moeti, the WHO's regional director for Africa.
Since the start of the outbreak, "there have been a total of nine laboratory-confirmed cases and 20 probable cases", the WHO said in a report on its website.
"Of the nine laboratory-confirmed cases, seven people have died and all probable cases have died."
Among the 20 probable cases, the patients had all the symptoms of the disease and had been in contact with confirmed cases, but samples could not be taken from their bodies, or they could not be treated, a WHO official told AFP Thursday.
The new cases have been reported from Kie-Ntem in the east, Litoral in the west and the Centro Sur provinces, all of which have borders with Cameroon and Gabon.
The epidemic is therefore now a serious problem in three of Equatorial Guinea's four mainland provinces.
- 'High alert' -
In eastern Africa, Tanzania said Tuesday that five people had died from the virus, while neighbouring Uganda, which had its last outbreak in 2017, said it was on "high alert".
The WHO said additional experts in epidemiology, logistics, health operations and infection prevention and control would be deployed in the coming days.
The agency is also supporting the health authorities in neighbouring Cameroon and Gabon to ramp up outbreak readiness and response capabilities.
The Marburg virus causes severe fever, often accompanied by bleeding and organ failure.
It is part of the so-called filovirus family that also includes Ebola, which has wreaked havoc in several previous outbreaks in Africa.
The suspected natural source of the Marburg virus is the African fruit bat, which carries the pathogen but does not fall sick from it.
The virus takes its name from the German city of Marburg, where it was first identified in 1967, in a lab where workers had been in contact with infected green monkeys imported from Uganda.
The animals can pass the virus to primates in close proximity, including humans, and human-to-human transmission then occurs through contact with blood or other body fluids.
Fatality rates in confirmed cases have ranged from 24 percent to 88 percent in previous outbreaks, depending on the virus strain and case management, according to WHO.
There are currently no vaccines or antiviral treatments, but potential treatments, including blood products, immune therapies and drug therapies, as well as early candidate vaccines, are being evaluated, the WHO says.
D.Kaufman--AMWN